PB Ratio: 8.47

Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/B ratio high or low?

The P/B ratio of 8.47 is 36% below its estimated 2-year average of 13.30, near the low end of its estimated 2-year range (0.71–52.53).

As of 2026-10-06T20:37:54.392Z. 60.56% below its estimated 12-month average of 21.47.

PVLA PB Ratio Metrics

P/B vs. estimated history

At 8.47, P/B is near its estimated 2-year median — higher than 49% of readings in its estimated 2-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Book Value Analysis

PB Ratio Formula & Definition

PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)

The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Palvella Therapeutics, Inc. (PVLA)?

The P/B ratio for PVLA stock is 8.47.

Is Palvella Therapeutics, Inc.'s P/B ratio high or low?

The P/B ratio of 8.47 is 36% below its estimated 2-year average of 13.30, near the low end of its estimated 2-year range (0.71–52.53).

What is the estimated TTM average P/B ratio for Palvella Therapeutics, Inc. (PVLA)?

The estimated TTM average P/B ratio for PVLA stock is 21.47.

Showing the most recent 260 of 455 data points. The chart above shows the full history.

Related Metrics